Therapy Areas: Central Nervous System
Belay Diagnostics partners with GenomOncology
26 March 2025 - Brain and spinal cord cancer testing provider Belay Diagnostics announced on Tuesday that it has partnered with GenomOncology (GO), a precision medicine software company that provides ...
Hikma announces Health Canada approval of KLOXXADO Nasal Spray for opioid overdose treatment
20 March 2025 - Hikma Pharmaceuticals plc (LON:HIK) (NASDAQ Dubai:HIK) (OTC:HKMPY) announced on Thursday the approval of KLOXXADO (naloxone HCl) Nasal Spray 8 mg by Health Canada for treating opioid o...
Plus Therapeutics secures FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda
6 March 2025 - Clinical-stage pharmaceutical company Plus Therapeutics Inc (Nasdaq:PSTV) announced on Thursday that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) ...
Latigo Biotherapeutics' LTG-001 receives US FDA Fast Track designation
4 March 2025 - Clinical-stage biotechnology company Latigo Biotherapeutics announced on Monday that it has received Fast Track designation (FTD) from the US Food and Drug Administration (FDA) for LTG-...
GenSight Biologics reports positive five-year resultsfor LUMEVOQ gene therapy
12 February 2025 - Biopharmaceutical company GenSight Biologics (Euronext: SIGHT) on Wednesday announced final efficacy and safety results from the REFLECT Phase III trial for LUMEVOQ (GS010; lenadoge...
Bain Capital to acquire Mitsubishi Tanabe Pharma in USD3.3bn deal
7 February 2025 - Alternative investment firm Bain Capital announced on Friday that it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) in a carve-out transacti...